Login
Super Investors Sio Capital Management, LLC
SC

Sio Capital Management, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$529M
Positions
55
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (48 quarters reported)

$697M $127M
Q4 14 Q2 17 Q4 19 Q2 22 Q4 24 Q3 26

$127M in Q4 2014 → $529M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Anteris Technologies Global 7.6% Trimmed 6.6% 5,179,464 $40.2M
GM Globus Med Inc 6.7% Added 58% 476,109 $35.7M
Gsk PLC 6.1% Added 54% 671,121 $32.3M
IP Icon Pub Ltd Co 4.5% Added 60% 140,999 $24M
SH Senseonics Hldgs Inc 4.4% Added 44% 2,290,860 $23.3M
Merck & Co Inc Put 4.1% New 150,000 $21.8M
Merck & Co Inc 4.0% New 145,485 $21.1M
Ideaya Biosciences Inc 3.6% Added 4.1% 500,117 $19.2M
Pfizer Inc Put 3.2% New 600,000 $17.1M
SL Sellas Life Sciences Group I Put 2.9% Unchanged 1,230,700 $15.1M
SS Sanofi Sa 2.8% Trimmed 2.2% 356,182 $14.7M
AT Allogene Therapeutics Inc 2.8% Trimmed 32% 9,104,151 $14.6M
Maximus Inc 2.7% Trimmed 62% 268,280 $14.3M
Relmada Therapeutics Inc 2.6% Added 262% 3,629,844 $13.7M
Viatris Inc 2.5% Trimmed 21% 755,490 $13.4M
AH Aveanna Healthcare Hldgs Inc 2.4% Added 174% 1,012,102 $12.6M
Replimune Group Inc 2.2% New 865,331 $11.5M
Tango Therapeutics Inc 2.0% Added 106% 428,860 $10.7M
Ani Pharmaceuticals Inc 2.0% Added 50% 146,268 $10.6M
Biomarin Pharmaceutical Inc 2.0% New 174,311 $10.5M
Celcuity Inc 1.9% Added 15% 126,339 $10M
Astrazeneca PLC 1.9% New 61,848 $9.99M
Rapport Therapeutics Inc 1.9% Trimmed 5.3% 291,231 $9.79M
Vir Biotechnology Inc 1.8% Trimmed 19% 873,375 $9.76M
The Cigna Group 1.7% Trimmed 41% 33,935 $9.22M
CC Cooper Cos Inc 1.7% New 158,053 $8.93M
Liquidia Corporation 1.6% New 282,000 $8.53M
Cybin Inc 1.3% Trimmed 57% 561,289 $6.9M
Protara Therapeutics Inc 1.1% Added 3.6% 1,991,339 $6.07M
Pmv Pharmaceuticals Inc 1.1% Added 38% 3,634,137 $6.07M
Aquestive Therapeutics Inc 1.1% Trimmed 14% 1,278,056 $5.92M
Ptc Therapeutics Inc 1.0% New 82,900 $5.37M
CP Corbus Pharmaceuticals Hldgs 1.0% New 766,364 $5.23M
RA Rainier Acquisition Corp 1.0% New 500,000 $5.1M
HM Haemonetics Corp Mass Put 0.9% New 44,700 $4.71M
Q32 Bio Inc 0.8% New 529,155 $4.38M
Serina Therapeutics Inc 0.8% Added 100% 2,000,000 $4M
Bright Minds Biosciences Inc 0.7% Added 1.6% 75,152 $3.74M
Savara Inc 0.6% Added 6.4% 657,104 $3.39M
Onkure Therapeutics Inc 0.6% Added 0.4% 1,082,965 $2.95M
An2 Therapeutics Inc 0.6% Added 3.4% 548,103 $2.92M
Immunome Inc 0.5% Added 6.4% 132,097 $2.84M
Zenas Biopharma Inc 0.5% Trimmed 54% 95,457 $2.57M
Ovid Therapeutics Inc 0.5% Unchanged 1,005,334 $2.5M
Aligos Therapeutics Inc 0.3% Unchanged 327,237 $1.84M
Fulcrum Therapeutics Inc 0.3% New 481,601 $1.78M
Alignment Healthcare Inc 0.3% New 184,424 $1.5M
Xilio Therapeutics Inc 0.3% Unchanged 152,464 $1.38M
Eyepoint Inc 0.2% Trimmed 40% 373,666 $1.22M
QI Qt Imaging Hldgs Inc 0.2% Added 2791% 440,446 $1.12M
Ibio Inc 0.2% Unchanged 904,268 $1.07M
Tela Bio Inc 0.1% Unchanged 636,300 $732K
Enveric Biosciences Inc 0.1% Added 83% 330,000 $490K
NM Neuroone Med Technologies Co 0.0% Unchanged 82,767 $85.3K
MM Modular Med Inc 0.0% Unchanged 26,190 $52.4K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Cencora Inc Exited −173,588 −$49.1M —
Maximus Inc Trimmed −446,987 −$23.8M 2.7%
Tyra Biosciences Inc Exited −695,315 −$22.2M —
Merck & Co Inc New +150,000 +$21.8M 4.1%
Merck & Co Inc New +145,485 +$21.1M 4.0%
WH Waystar Hldg Corp Exited −925,834 −$19M —
Pfizer Inc New +600,000 +$17.1M 3.2%
Oruka Therapeutics Inc Exited −177,118 −$16.9M —
CC Cross Ctry Healthcare Inc Exited −1,098,393 −$14.5M —
GM Globus Med Inc Added +174,293 +$13.1M 6.7%

Showing the 10 largest of 66 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
IP Icon Pub Ltd Co Trimmed −218,172 −$37.9M 2.5%
Dianthus Therapeutics Inc Trimmed −310,791 −$30.3M 1.0%
AT Allogene Therapeutics Inc New +13,323,431 +$27.7M 4.6%
Corcept Therapeutics Inc Exited −674,759 −$27.2M —
Livanova PLC Exited −421,615 −$26.8M —
GM Globus Med Inc New +301,816 +$23.8M 3.9%
Cencora Inc Added +72,694 +$20.6M 8.1%
SL Sellas Life Sciences Group I New +1,230,700 +$18.2M 3.0%
Ideaya Biosciences Inc New +480,383 +$17.9M 3.0%
Embecta Corp Exited −1,847,850 −$16.3M —

Showing the 10 largest of 82 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 14, 2026

Company Action Shares changed Value of change % of portfolio
The Cigna Group Exited −172,203 −$47.4M —
SS Sanofi Sa Trimmed −732,015 −$35.3M 1.7%
Celcuity Inc Trimmed −283,224 −$32.3M 3.2%
Zimmer Biomet Holdings Inc Trimmed −323,029 −$29.2M 0.8%
Rhythm Pharmaceuticals Inc Exited −265,700 −$28.4M —
Corcept Therapeutics Inc New +674,759 +$27.2M 3.9%
Cencora Inc Added +84,994 +$26.7M 4.5%
Kenvue Inc Exited −1,465,442 −$25.3M —
WH Waystar Hldg Corp Added +1,028,511 +$24.8M 5.7%
Gsk PLC New +385,879 +$21.3M 3.1%

Showing the 10 largest of 79 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
The Cigna Group New +172,203 +$47.4M 7.5%
Zimmer Biomet Holdings Inc New +385,642 +$34.7M 5.5%
Celcuity Inc Trimmed −309,459 −$30.9M 7.5%
Rhythm Pharmaceuticals Inc New +265,700 +$28.4M 4.5%
Organon & Co New +3,421,765 +$24.5M 3.9%
Icon PLC New +127,202 +$23.2M 3.6%
WH Waystar Hldg Corp New +613,725 +$20.1M 3.2%
Livanova PLC New +322,382 +$19.8M 3.1%
SS Sanofi Sa Added +408,983 +$19.8M 7.4%
Disc Medicine Inc Trimmed −227,201 −$18M 0.7%

Showing the 10 largest of 61 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 13, 2025

Company Action Shares changed Value of change % of portfolio
Celcuity Inc New +786,526 +$38.9M 9.8%
Alkermes PLC New +674,840 +$20.2M 5.1%
Bright Minds Biosciences Inc Trimmed −321,574 −$19.5M 2.9%
SS Sanofi Sa Added +375,203 +$17.7M 6.7%
Henry Schein Inc New +219,207 +$14.5M 3.7%
GM Globus Med Inc Exited −245,570 −$14.5M —
Kenvue Inc New +844,000 +$13.7M 3.5%
Dianthus Therapeutics Inc Added +341,680 +$13.4M 5.8%
Neurocrine Biosciences Inc Exited −100,725 −$12.7M —
Gsk PLC New +268,873 +$11.6M 2.9%

Showing the 10 largest of 49 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

Company Action Shares changed Value of change % of portfolio
Icon PLC Exited −203,311 −$35.6M —
Zimmer Biomet Holdings Inc Exited −187,685 −$21.2M —
Labcorp Holdings Inc Exited −83,873 −$19.5M —
Teleflex Incorporated Exited −107,780 −$14.9M —
CD Centene Corp Del New +262,500 +$14.2M 5.4%
Disc Medicine Inc Added +211,276 +$11.2M 5.8%
Neurocrine Biosciences Inc Trimmed −86,848 −$10.9M 4.8%
Embecta Corp Trimmed −1,076,444 −$10.4M 0.1%
IL Idexx Labs Inc New +18,000 +$9.65M 3.7%
Sanofi New +187,500 +$9.06M 3.5%

Showing the 10 largest of 59 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
The Cigna Group Exited −98,003 −$27.1M —
Merck & Co Inc New +270,596 +$24.3M 7.2%
Neurocrine Biosciences Inc New +187,573 +$20.7M 6.2%
Sanofi Exited −387,000 −$18.7M —
GM Globus Med Inc New +207,000 +$15.2M 4.5%
Biomarin Pharmaceutical Inc New +141,134 +$9.98M 3.0%
Viatris Inc Exited −730,000 −$9.09M —
Organon & Co Exited −606,410 −$9.05M —
Embecta Corp Added +682,039 +$8.7M 4.2%
HM Haemonetics Corp Mass New +133,966 +$8.51M 2.5%

Showing the 10 largest of 47 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Icon PLC New +195,500 +$41M 11.5%
Intuitive Surgical Inc Exited −59,000 −$29M —
Teva Pharmaceutical Industries Ltd Exited −1,349,274 −$24.3M —
The Cigna Group Added +71,500 +$19.7M 7.6%
Sanofi New +387,000 +$18.7M 5.3%
Maximus Inc Added +226,281 +$16.9M 8.0%
Bright Minds Biosciences Inc New +451,793 +$16.3M 4.6%
Labcorp Holdings Inc Trimmed −60,000 −$13.8M 7.3%
Anteris Technologies Global New +2,370,000 +$13.2M 3.7%
Kenvue Inc Exited −474,741 −$11M —

Showing the 10 largest of 46 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support